The germ cell nuclear factor of Xenopus laevis (xGCNF; NR6A1) is a nuclear orphan receptor that is predominantly expressed during neurula and late tailbud stages. As a strategy to analyze the role of xGCNF in embryogenesis, we have induced a gain of function by overexpression of full-length (fl) GCNF and a functional inhibition by a dominant-negative (dn) GCNF. Early events of embryogenesis including gastrulation and neurulation were not affected and the expression of several early mesodermal markers was normal. Yet specific defects were observed upon organogenesis. Ectopic posterior overexpression of the full-length xGCNF caused posterior defects and disturbed somite formation. In contrast, expression of dnGCNF interfered with differentiation of the neural tube and affected the differentiation of anterior structures, including the cement gland and the eyes. Embryos affected by dnGCNF were rescued by coexpression of flGCNF. After expression of dnGCNF, mRNA encoding the retinoic acid receptor xRARg 2 was selectively suppressed anteriorly. From the distinct phenotypes obtained, we conclude that GCNF has an essential function in anteroposterior differentiation during organogenesis.
Introduction
Nuclear orphan receptors share the domain structure of the nuclear hormone receptors and their ability to regulate the expression of specific target genes by binding to a response element in the promoter region. The germ cell nuclear factor (GCNF; NR6A1) is a nuclear orphan receptor that is to date the first and only member of the 6th subfamily of the nuclear hormone receptors. The name GCNF gives credit to the fact that the murine receptor was first detected in male germ cells (Chen et al., 1994; Hirose et al., 1995; Katz et al., 1997) . A Xenopus GCNF (xGCNF) was found independently and the mRNA encoding the xGCNF is by far more abundant in the embryo during neurulation and early organogenesis than it is in male germ cells of the adult. Zygotic transcription reaches a maximum during neurulation and an anteroposterior gradient of transcripts is established during gastrulation and neurulation. Transcripts specific for xGCNF are present in anterior ectoderm and dorsal mesoderm, and are especially abundant in the presumptive neuroectoderm during neurulation (Joos et al., 1996) . Subsequently the murine GCNF was also described in embryos and in the developing brain (Süsens et al., 1997; Bauer et al., 1997) . A human GCNF has also recently been described (Süsens and Borgmeyer, 1996; Kapelle et al., 1997; Lei et al., 1997) .
Because of the late expression of xGCNF, a role for this orphan receptor in the early events of mesoderm induction and neural induction is unlikely. The expression pattern rather suggests a function for xGCNF in anteroposterior patterning during neurulation and early organogenesis. During neurulation and the subsequent tailbud stages, a number of differentiation events proceed in the craniocaudal direction: In the ectoderm the neural plate segregates from the epidermis between neurula stages 13.5 and 15 and it thickens simultaneously, except for a thin stripe along the dorsal midline (Nieuwkoop and Faber, 1967) . Interestingly, this stripe contains less xGCNF mRNA than the rest of the neural plate (Joos et al., 1996) . Similarly, segregation of the neural crest from the neural plate and from the neural tube, as well as the differentiation of the spinal cord proceed in craniocaudal direction. In the axial and paraxial mesoderm, vacuolization of the notochord and somitogenesis also proceed in craniocaudal direction. (Nieuwkoop and Faber, 1967) .
Based on its expression pattern, xGCNF could be involved in the regulation of organogenic processes with respect to the anteroposterior axis. If this is the case, organogenesis would be expected to be sensitive to the dose of functional GCNF at a given time and location. We have therefore explored whether ectopic overexpression of the functional full-length xGCNF might disturb organogenesis. Furthermore, we have assessed the influence of a dominant negative xGCNF (dnGCNF) on development, particularly in the dorsoanterior structures that normally express the receptor.
Results

xGCNF is a nuclear protein in embryos
As transcription of xGCNF mRNA is spatiotemporally regulated in embryos of X. laevis (Joos et al., 1996) , we have studied the expression of xGCNF during embryogenesis at the protein level, with application of a polyclonal antiserum. On developmental Western blots, a band of the expected M r of approximately 50 × 10 3 , was detected from the late gastrula stage 12.5 onward. The level of this antigen increases during neurulation and does not change significantly between the neurula, stage 19, and late tailbud, stage 28 (Fig. 1A) . The antigen obviously persists after the level of the xGCNF mRNA has decreased (Joos et al., 1996) . Whole mount immunofluorescence staining demonstrates that xGCNF is found in most cell nuclei during neurulation and tailbud stages. Nevertheless, the pattern of protein expression is dynamic, with almost all regions of the embryo expressing xGCNF at a certain developmental stage ( Fig. 1B and data not shown). Fig. 1B-D show a longitudinal section of a tailbud embryo at stage 24 stained for xGCNF (B), for xRARg (C), and for DNA to identify cell nuclei (D) . Anteriorly, all nuclei contain xGCNF, except for those in the eye anlagen and staining is weak in part of the forebrain (Fig. 1B) . In the notochord (data not shown), and in the somites (Fig. 1B) , the intensity of nuclear staining decreases in the craniocaudal direction, with little if any xGCNF in the posterior presomitic mesoderm. The whole epidermis contains xGCNF, but staining is very weak in the prospective tail. Posteriorly, expression of xGCNF and xRARg, another nuclear receptor, is almost mutually exclusive at stage 24 (compare Fig. 1B,C) . The xGCNF predominates in the epidermis, the endoderm, and the differentiated mesoderm, whereas xRARg is mainly found in the posterior part of the neural tube and in the undifferentiated mesoderm of the posterior wall (Gont et Fig. 1 . xGCNF protein is predominantly expressed during tailbud stages. (A) Developmental Western blot. A polypeptide of the expected M r of 50 × 10 3 (arrow) is detected by a polyclonal mouse serum between the midneurula and early tadpole stages. A weak signal was detected at this position at late gastrula, stage 12.5, after long exposure (data not shown). A second signal results from a nonspecific reaction of the polyclonal antiserum. (B,C) xGCNF and xRARg nuclear proteins are differentially expressed with respect to the anteroposterior axis. Slightly oblique parasagittal section through a tailbud embryo at stage 24 after wholemount double immuno-staining with mouse anti xGCNF(B) and rabbit anti xRARg (C), as described in Experimental Procedures. Counterstaining of all nuclei with DAPI is shown in (D). epi, epidermis; en, endoderm; fb, forebrain; e, eye anlage; so, somites; no, notochord; nt, neural tube; pw, posterior wall. Anterior is to the left. Scale bar, 200 mm. al., 1993) . In the anterior, nuclei of the ventral head mesenchyme contain both receptors. Interestingly, both receptors are absent from most nuclei of the eye anlagen at this stage (Fig. 1B,C) . At late tailbud, stage 30, xRARg persists mainly in the head mesenchyme, gill arches, and tip of the tail Dreyer, 1991, 1993) . The xGCNF antigen persists in the epidermis, somites, and endoderm and in the central nervous system its expression becomes restricted to specific ventrolateral cell nuclei of the midbrain and hindbrain area and to part of the spinal cord (to be published elsewhere). Our immunohistological analysis substantiates our previous observations by in situ hybridization on the spatiotemporally regulated pattern of xGCNF expression during embryogenesis (Joos et al., 1996) . Although the murine homologue of xGCNF has been primarily associated with the differentiation of neuronal cells in culture (Bauer et al., 1997; Heinzer et al., 1998) and in embryos (Bauer et al., 1997; Süsens et al., 1997) , our results demonstrate the transient presence of xGCNF protein in differentiating cells of all germ layers (Fig. 1B) .
Ectopic expression of myc-tagged xGCNF proteins in embryos of X. laevis
The specific expression pattern of xGCNF during embryogenesis suggests that organogenesis may require a defined level of functional xGCNF, and therefore ectopic expression of the protein might interfere with organogenesis. Overexpression of the full-length protein should reveal a gain of function phenotype, whereas expression of a dominant negative protein should lead to a loss of function of the endogenous GCNF. We generated a nonfunctional GCNF by deleting the N-terminus, including part of the DNA binding domain. Experimental evidence from several laboratories suggests that efficient binding of GCNF to its target requires homodimer formation (Chen et al., 1994; Hirose et al., 1995; Joos et al., 1996; Borgmeyer, 1997; Bauer et al., 1997; Yan et al., 1997) and there is no evidence for heterodimer formation with the retinoid X receptor RXR (Borgmeyer, 1997; Bauer et al., 1997; and our unpublished observations) , therefore a non-DNA-binding GCNF mutant is likely to act as a dominant negative by heterodimer formation with the intact GCNF, provided that the dimerization interface is preserved.
To test this hypothesis, full-length and N-terminally truncated polypeptides translated in vitro were tested for binding to DNA containing the response element DR0, which is a direct repeat of the motif AGGTCA. As expected, only the full-length form of the xGCNF bound to DR0 (Fig. 2A, lane  1) , whereas the N-terminal truncation completely inhibited binding to DR0 (lane 5). When increasing amounts of the truncated form were mixed with a constant amount of fulllength xGCNF, less DR0 was bound ( Fig. 2A, lanes 2-4) . No complexes migrating faster than the xGCNF homodimer were observed, indicating that heterodimers do not bind efficiently to the response element. We therefore expected that an excess of the truncated xGCNFDN would impair the function of endogenous xGCNF in the embryo and would therefore function as a dominant negative (dn) GCNF in vivo.
For ectopic expression studies, the full-length and the 5′ truncated xGCNF cDNA were cloned in frame behind a cDNA encoding six myc-epitopes in the pCS2 + MT expression vector as depicted in Fig. 2B . For transient expression of fl and dnGCNF, mRNA encoding the fusion proteins shown in Fig. 2B was transcribed in vitro. We routinely injected 120 pg of mRNA per embryo into one blastomere at the two-cell stage. To adjust the amount of mRNA required for the synthesis of an adaquate amount of protein in the embryo, we performed Western blots after injection of the mRNAs. The monoclonal antibody (mAB) 9E10 directed against the myc-tag exclusively recognized the polypeptides translated from the injected mRNAs (upper panels of Fig. 3 ), whereas the xGCNF antiserum allowed the direct comparison of the amounts of endogenous and exo- (Joos et al., 1996) . xGCNF and xGCNFDN cDNA was cloned into the vector pcs2 + MT (Rupp et al., 1994) . mRNA encoding myc-tagged protein was injected to allow distinction between endogenous and exogenous GCNF protein.
genous xGCNF protein (middle panels of Fig. 3 ). The mAB b7-1A9, directed against nucleoplasmin (Zimmer et al., 1988) , provided a loading control (lower panels of Fig. 3 ). Protein from uninjected control embryos and from embryos injected with mRNA encoding the fl or dnGCNF was analyzed at the midgastrula, stage 11, neurula, stage 18, and tailbud, stage 23. After mRNA injection at the 2-cell stage, myc-tagged proteins were detected in significant amounts at stage 11, prior to accumulation of the endogenous xGCNF. Myc-tagged proteins were present until at least the tailbud stages in amounts comparable to the level of endogenous xGCNF (Fig. 3) . About 120 pg of exogenous mRNA were required to obtain about equal amounts of endogenous and exogenous proteins per embryo. This corresponds to a severalfold excess of the exogenous protein near the site of injection, because the injected mRNA does not diffuse throughout the embryo (see below).
In order to determine the maximally tolerable level of exogenous mRNA per embryo, 30-240 pg of mRNA encoding dn or flGCNF were injected at the two-cell stage. Although early development appeared unaffected, the percentage of embryos showing normal development beyond neurulation decreased significantly with increasing dose of mRNA injected, and during tailbud stages most embryos became extremely stunted, although their main body axis could still be identified. In most subsequent experiments 120 pg of mRNA was injected into a single blastomere at the two-cell stage, leaving one hemisphere as control. For phenotypic analysis we concentrated on embryos with a discernible main body axis and specimens severely damaged by exogastrulation or spina bifida were scored as not evaluated in Table 1 .
Overexpression of flGCNF perturbs tail and somite development
Injection of mRNA encoding flGCNF into one blastomere at the two-cell-stage resulted in embryos with a short main body axis at late tailbud stage 30. At later stages, multiple and crippled tail tips were found in a percentage of injected embryos that was dependent on the batch of eggs, whereas heads usually developed normally (Fig. 4 and data not shown). In eight independent experiments compiled in Table 1 , a total of 934 embryos surviving to the end of neurulation were evaluated. The embryos are listed according to their most characteristic externally visible defects. In all of the experiments malformations at the posterior end were most frequently seen after overexpression of the flGCNF. Of a total of 331 evaluated embryos injected with flGCNF mRNA, 45% had significant defects in posterior axis formation. Between individual experiments, this percentage varied between 31 and 58%. As compiled in Table 1 , this phenotype was more rarely observed after expression of dnGCNF (12% of 265 specimens) or in control embryos (5% of 338 specimens).
Aside from tail defects, disturbed patterns of somitogenesis were also found in 47% of all tadpoles after overexpression of flGCNF (Table 1) . Although these tadpoles had differentiated muscles and were able to swim, the somite pattern appeared to be significantly compressed in areas of maximal overexpression of the flGCNF. Different degrees of local irregularity of the somites are illustrated in Fig. 5B -D. The regular somite pattern of a control sibling at stage 40 is shown in Fig. 5A . The arrow in Fig. 5B points to a slight irregularity in the pattern, whereas the specimens shown in Fig. 5C ,D have irregular somite boundaries and a group of compressed somites. In the example shown in Fig. 5D , myctagged flGCNF could still be traced in the endoderm in the posterior third of the tadpole at stage 40, just beneath the area of maximal compression of the somites. A disturbance of somite formation, although on average at least as frequently observed as the posterior defects, is however, not exclusively associated with the overexpression of flGCNF but was also observed after expression of the dnGCNF (see Fig. 3 . Expression of xGCNF proteins in embryos after injection of mRNA at the two-cell stage. Embryos were injected with 120 pg of mRNA encoding dnGCNF or with 40 pg flGCNF mRNA into one blastomere at the two-cell stage as indicated at the top. Control embryos were injected with water. Injected embryos were analyzed by Western blotting at gastrula, stage 11, neurula, stage 18, or tailbud, stage 23, as indicated at the bottom. Upper panels: myc epitope tag of protein translated from exogenous mRNA detected by mAB 9E10. Middle panels: Exogenous and endogenous polypeptides detected by the antiserum directed against xGCNF. Lower panel: Loading control, endogenous nucleoplasmin is detected by mAB b7-1A9 (Zimmer et al., 1988). below). On the other hand, somitogenic defects were observed in only 5% of 338 control embryos (Table 1) .
Doubling the dose of mRNA per embryo increased the percentage of severely damaged embryos that were not evaluated, but increased the percentage of specific defects only slightly. This effect is seen in Table 1 , where the experiments with injection of two times 120 pg of mRNA into both blastomeres are marked with an asterisk. Posterior defects after overexpression of flGCNF were seen in 57% of these embryos, as compared to 42% after injection of 120 pg and the percentage of somitogenic defects increased from 54 to 61%. In conclusion, regular somitogenesis apparently requires a normal level of GCNF and tail development is sensitive to ectopic overexpression of functional GCNF. In contrast, head formation can proceed normally in the presence of a moderate excess of flGCNF.
Expression of a dnGCNF affects development of head and neural tube
Whereas posterior defects prevailed after overexpression of the flGCNF, expression of the dnGCNF resulted in frequent abnormalities in head development. This was observed in seven independent experiments with injection of mRNA encoding dnGCNF into one or both blastomeres at the two-cell stage (Table 1) . Of 265 embryos scored, Embryos that developed beyond end of neurulation (stage 20) were evaluated at stage 23 in experiment V, and at stage 30 in all other experiments. Embryos showing severe malformations of the exogastrula and spine bifida types, were scored as not evaluated. Anterior defects comprized narrow or short heads with often one eye rudimentary or not detected from the outside (Figs. 6C and 8A). Somitogenic defects are illustrated in Fig. 5 . Embryos with 'posterior' defects were usually shorter than normal and had round (Fig. 6B) , crippled, or multiple tail tips (Fig. 4) . Experiments with double injection of 120 pg mRNA into both blastomeres are marked with an asterisk. Localization of the myc-tagged protein 2 days after injection, when control siblings had reached stage 30 to 33, was possible in more than 90% of the embryos tested. In the experiments marked with a $, mRNA encoding GFP was co-injected with the xGCNF-specific mRNA. This control allowed us to locate the area of maximal expression by inspection of the living embryos under UV light. In this set of experiments, GFP was detected in more than 90% of all injected embryos between late gastrula and at least stage 30.
about 53% had narrow or short heads, often in combination with rudimentary or even missing cement glands, eyes, or ear cups. In contrast, anterior defects were observed in 17% of 331 embryos after overexpression of the flGCNF and only 6% of 338 embryos after expression of GFP or bgalactosidase had abnormal heads (Table 1) . In order to correlate the observed defects with the site of injection, 30 pg of mRNA was injected into one marginal or vegetal blastomere at the 32-cell stage. The results of this series of experiments were similar to those shown in Table  1 , albeit with weaker effects due to the lower dose per embryo (data not shown). Subsequently, areas of maximal expression were identified by wholemount immunostaining of the specimens with mAB 9E10 that detects the myctagged proteins (Fig. 6) . Detection of the myc-tagged proteins allowed a retrospective identification of the lineage of the injected cells. Fig. 6 shows tailbud stage 30 embryos after anti-myc-tag whole mount immunostaining. The control embryos show that a comparatively high amount of MT-GFP is compatible with normal development (Fig. 6A ). Fig.  6B shows two examples of only moderately damaged embryos after ectopic expression of MT-flGCNF throughout the dorsal axis. Both heads appear normal, although the MT-flGCNF protein is found around the eyes. Both tailbuds are short and round. A ventral edema is seen in the upper Fig. 4 . Posterior defects after overexpression of full-length GCNF. A normal embryo at stage 40 is shown at the upper left. The others are siblings with a short main body axis, edema, and defects in tail development after injection of 120 pg of mRNA encoding flGCNF into one blastomere at the two-cell stage. Scale bar, 100 mm. embryo at a site of abundant antigen. Fig. 6C shows two embryos with predominantly anterior defects after expression of dnGCNF along the main body axis. In addition, the upper specimen is significantly stunted. After wholemount staining for the myc-tagged proteins, serial sections were cut and counterstained with toluidine blue for the histological analysis of the defects (Fig. 7) . Most individuals that expressed dnGCNF but had no overt spina bifida had lesions in the neural tube where the dnGCNF was localized (Fig.  7A ) and in about 30% of these cases the neural tube was not perfectly closed (Fig. 7D ). This phenotype was histologically analyzed in specimens from four independent experiments after expression of dnGCNF (data not shown). Lesions in the neural tube were rarely observed after overexpression of flGCNF (Fig. 7B,C) . The specimen shown in Fig. 7B has MT-flGCNF expressed in the roof plate, yet the neural tube is closed. In Fig. 7C a disorganized somite is seen at the site of expression of MT-flGCNF. Single cells containing high amounts of myc-tagged dnGCNF or flGCNF often appeared undifferentiated or necrotic or not properly integrated into the surrounding differentiated tissue (e.g. in Fig. 7D in the upper left neural tube). Furthermore, in embryos expressing dnGCNF a clearcut separation of the anlagen of different organs in the head and anterior trunk region was frequently lacking (right parts of Fig. 7A,D) and the notochord appeared to be fused to the adjacent somites in many instances (data not shown). The presence of MT-GFP did not affect the differentiation of the neural tube (Fig.  7E) . The sites of myc-tagged protein expression were confirmed on adjacent sections that were not stained with toluidine blue (data not shown).
To further scrutinize the specificity of the effects of dnGCNF expression, we performed rescue experiments showing that frequency and strength of the typical defects occuring after injection of mRNA encoding dnGCNF were reduced after coinjection of an equal amount of mRNA encoding the flGCNF (Table 2) . In experiments 1 and 2, mRNA was injected into a single blastomere at the two-cell stage and in experiment 3 both blastomeres were injected. In three independent experiments, addition of functional GCNF to embryos expressing dnGCNF increased the percentage of survivors. Importantly, the average percentage of normal looking embryos increased from 28% to 58% and the average percentage of embryos with defective or missing eyes and cement glands was reduced from 57 to 36%. Furthermore, the lesions were less severe after coinjection of both mRNAs (Fig. 8) . Representative specimens evaluated after injection of dnGCNF mRNA into both blastomeres are shown in Fig. 8A . These embryos have no externally visible eye anlagen and the cement glands are missing or extremely cryptic. For comparison, two anomalous embryos observed after coinjection of mRNA encoding dnGCNF and flGCNF are shown in Fig. 8B . These embryos appear significantly closer to normal phenotypes, although the eye anlagen are reduced in size as compared to the GFP expressing controls shown in Fig. 8C . Importantly, rescue by flGCNF prevented the most extreme phenotypes with eyes and cement glands completely missing.
Markers of early mesoderm differentiation are not affected by dnGCNF
Amazingly, the specific defects observed after injection of mRNA at the two-cell stage became visible after the embryos had appeared normal up to neurula stages, with no indication of an abnormal gastrulation or neurulation. No higher incidence of exogastrulation than in the controls injected with mRNAs encoding b-galactosidase or GFP was observed and embryos with severe exogastrulation and spina bifida were not evaluated.
Although the endogenous xGCNF was not expressed before the end of gastrulation (Fig. 1A) and therefore unlikely to be involved in the early events of mesoderm induction, the exogenous GCNF proteins were found prior to the endogenous receptor (Fig. 3) and might therefore interfere with early events of embryogenesis.
To investigate whether markers that are differentially expressed during early gastrula stages are affected, we injected albino embryos into both blastomeres at the twocell stage with two times 120 pg of mRNA encoding dn or flGCNF plus 30 or 120 pg of GFP mRNA as an in vivo tracer. Embryos were fixed and subjected to whole mount in situ hybridization at gastrula stages. All specimens expressed chordin mRNA at the dorsal lip at stages 10-10.5, irrespective of whether mRNA encoding dnGCNF, flGCNF, or GFP was injected (data not shown). This finding precludes that premature expression of dnGCNF could ventralize the embryo, since after ventralization of embryos by UV-light expression of chordin mRNA is suppressed (Sasai et al., 1996) .
Similarly, the mesodermal marker brachyury (xbra; Smith et al., 1991) was expressed in its normal ringshaped domain at stage 10.5-11 after ectopic expression of dnGCNF (Fig. 9C,E) or flGCNF (Fig. 9F ). An irregular pattern of xbra expression was observed in specimens with abnormal gastrulation that normally did not survive until neurula stage. Importantly, subsequent localization of the exogenous protein by an anti-myc-tag antibody showed that xbra was transcribed at the sites of maximal Fig. 7 . Defective development of the neural tube after expression of dnGCNF. Embryos injected with 30 pg of mRNA into a dorsal marginal blastomere at the 32-cell stage were fixed at stage 30 and immunostained for myc-tagged proteins as described in Fig. 6 . Embryos with significant expression of myc-tagged proteins but without overt spina bifida were embedded in Technovit and serial transverse sections were analyzed for the exogenous protein by the brown peroxidase label. Failures in differentiation (A) or closure of the neural tube (D) were frequently found were MT-dnGCNF was produced (A,D). After overexpression of flGCNF (B,C), the neural tube was usually closed, even when it contained labeled cells, as seen in the roof plate in (B). Note disturbed somitogenesis on the injected side in (C). Differentiation of the neural tube remained unaffected after ectopic expression of MT-GFP (E). Alternating sections were briefly stained with toluidine blue to facilitate histological analysis (A-E) or remained unstained for most sensitive detection of the myc-tagged proteins (not shown). Only the dorsal part of each section is shown. protein expression of dnGCNF or flGCNF (Fig. 9E,F) . Furthermore, after expression of dnGCNF, the pattern of myoDb (Rupp and Weintraub, 1991) mRNA was not significantly affected at midgastrula stages (Fig. 9A) . At later stages, however, the transcriptional pattern of myoD was affected in embryos with significantly disturbed organogenesis after ectopic expression of fl or dnGCNF (data not shown). These results are in agreement with the notion, that dnGCNF interferes with the normal function of the endogenous GCNF, which is not yet present in significant amount at early gastrula.
Molecular marker gene expression after interference with xGCNF function
RT-PCR analysis of selected molecular markers was used to corroborate the existence of distinct phenotypes after ectopic expression of either dn or flGCNF. Because of the spatiotemporal expression pattern of the endogenous xGCNF and because of the absence of specific lesions up to the end of neurulation, we investigated genes that are expressed after gastrulation in a distinct pattern with respect to the anteroposterior axis, or are restricted to specific tissues during organogenesis. After exogenous expression of either full length or dnGCNF, RNA was prepared from total and half embryos at stages 23 and 27, and from anterior, middle, and posterior thirds of early tadpoles at stage 30. Embryos injected with mRNA encoding b-galactosidase or GFP were used as controls. Of the markers used, xRARg 2 and HoxB9 have a differential expression pattern with respect to the anteroposterior axis in normal embryos. The mRNA of HoxB9, previously called XlHbox6, is found posteriorly (Sharpe et al., 1987 ) and xRARg2 mRNA is found primarily in the anterior and posterior regions of the embryo, with a peak of expression during midneurula stages, coincident in time with the maximal expression of endogenous xGCNF mRNA (Ellinger-Ziegelbauer and Dreyer, 1991; Pfeffer and De Robertis, 1994; Joos et al., 1996) . As seen in lanes 4-6 of Fig. 10 , the results of the RT-PCR of the controls reflect the anteroposterior distribution Embryos were injected at the two-cell stage into a single blastomere (experiments 1 and 2), or into both blastomeres (experiment 3) with mRNAs encoding dnGCNF and GFP, dnGCNF and flGCNF, or GFP alone. The total amount of mRNA injected per embryo was 200 pg in experiments 1 and 2 and 120 pg in experiment 3. Embryos with lethal cytolysis or massive exogastrulation were removed. In three different experiments, the percentage of embryos that survived beyond neurulation was lowest in the batches expressing dnGCNF (38 to 55%). After coexpression of dnGCNF and flGCNF, the percentage of survivors was increased to between 60 and 70%. As illustrated in Fig. 8 , the anterior defects were qualitatively less severe in the rescued embryos. In almost all of the embryos with 'anterior defects', eyes were too small or one or both eye anlagen were missing. In the batches injected with dnGCNF mRNA alone, about one third of the anteriorly defective specimens had no cement gland. This phenotype was very rarely found after rescue by flGCNF Posterior defects were significantly less frequent than anterior defects and are not listed in this table.
of xRARg 2 and of HoxB9 mRNA as it was previously found by in situ hybridization. Products resulting from the RT-PCR analysis were quantified by means of a phosphorimager and the intensity of the EF1a band was used as an internal standard in order to compare experimental and control embryos. After exogen- Table 2 , excluding the specimens with spina bifida or those scored as not evaluated. Anterior is to the right. Fig. 9 . Early expression of mesodermal markers is unaffected by dnGCNF or flGCNF. Albino embryos were injected in both blastomeres at the two-cell stage with two times 120 pg of mRNA encoding dnGCNF (A,C,E), flGCNF (F). In addition, 30 pg of GFP mRNA per blastomere was injected to allow monitoring of protein expression in living embryos. Injected embryos were selected for significant expression of GFP at early gastrula, fixed at stage 10.5 to 11, and subjected to wholemount in situ hybridization as described, using a digoxigenin-labeled antisense RNA specific of MyoDb (A,B) or xbra (C-F). Noninjected controls are shown in (B) and (D). After in situ hybridization, the specimens shown in E and F were stained with mAB 9E10 to localize the areas of maximal expression of the myc-tagged dnGCNF (E) and flGCNF (F) proteins.
ous expression of dnGCNF, we observed no significant change in the amount of HoxB9 transcript, whereas the level of xRARg 2 transcript was reduced anteriorly to about 50% (Fig. 10A, lanes 1-4) . In three independent experiments after injection of 120 pg of dnGCNF mRNA into a single blastomere, the relative amount of xRARg 2 mRNA in the anterior third varied between 39 and 78% of that in the control. After injection of both blastomeres with 120 pg each, this amount was 27% that of the control. The reduction of the amount of xRARg 2 transcript after dnGCNF mRNA injection was substantiated by in situ hybridization of embryos at stage 30 (data not shown).
The xRARg 2 mRNA located posteriorly was apparently unchanged as observed by both RT-PCR and by in situ hybridization ( Fig. 10A and data not shown) . Similarly, a reduction in the relative amounts of xRARg 2 mRNA to about 60% of the controls was seen in anterior but not posterior halves of embryos analyzed at stage 23 and stage 27 after expression of dnGCNF (data not shown).
Overexpression of flGCNF had no significant effect on xRARg 2 or HoxB9 (lanes 4-9 of Fig. 10A,B) . Similarly, no apparent changes in the amount of xRARg 1 mRNA were induced in our RNA injection experiments (data not shown). Furthermore, RT-PCR analysis was performed to compare the abundance of mRNAs specific for slug (Mayor et al., 1995) , snail (Essex et al., 1993) , activin receptor II (Mathews et al., 1992) after ectopic dn and flGCNF expression. Any changes observed in the amounts of these markers as compared to the controls were subtle and usually less than a factor of two (data not shown).
Because our histological analysis suggested that loss of GCNF function by exogenous expression of dnGCNF resulted in fusion or lack of separation of several anlagen during organogenesis, we included fibronection in our analysis. Transcripts encoding fibronectin are expressed ubiquitously in embryos throughout the tailbud stages (Lee et al., 1984) . After overexpression of flGCNF, the relative amount of fibronectin mRNA was increased, on average, by a factor of about two in 5 independent experiments (Fig. 10A , lanes 4-9, and data not shown). This increase was not consistently seen in a particular part of the embryo at stage 30 and it was not observed at earlier stages of development (data not shown).
Wholemount immunofluorescent staining of injected embryos for fibronectin highlighted the defects observed in organogenesis (Fig. 11) . In sections, ectopic boundaries containing fibronectin were found in the notochord and somites after expression of dnGCNF (Fig. 11B) , and even more frequently after overexpression of flGCNF (Fig. 11C) . The specimen shown in Fig. 11C shows an apparent duplication of the notochord after overexpression of flGCNF. In another specimen sectioned horizontally, somitogenesis was severely affected in the part of the tail which overexpressed flGCNF (Fig. 11D) .
In summary, these examples corroborate our observations of the distinct phenotypes produced by expression of the fl and the dnGCNF. Because the changes induced by injected fl or dnGCNF transcripts on the amounts of xRARg 2 and of fibronectin did not exceed a factor of two, they may represent an indirect consequence of interference with GCNF function.
Discussion
Exogenous expression of dn and flGCNF produce distinct phenotypes
Investigation of the normal pattern of xGCNF expression in embryos revealed a widespread, although transient, presence of the nuclear protein in all three germ layers throughout neurulation and early tailbud stages (Fig. 1B and data  not shown) . Therefore, interference with GCNF function in embryos was likely to result in pleiotropic effects on cell differentiation.
Embryos after exogenous expression of dn and flGCNF looked normal until the end of neurulation and the transcriptional pattern of the early mesodermal markers chordin, xbra, and myoD was essentially normal after injection of fl or dnGCNF mRNA (Fig. 9 and data not shown), indicating that xGCNF is not involved in the early processes of gastrulation and neurulation. Our results show that functional xGCNF is required for the differentiation of organs derived from the dorsoanterior ectoderm and mesoderm, since dnGCNF primarily disturbed differentiation of the neural tube, the head and sense organs, whereas the effects on differentiation of the tail were minor. Conversely, an overdose of functional GCNF affected primarily the differ- Fig. 10 . Multiplex RT-PCR analysis of transcripts after exogenous expression of fl and dnGCNF. Embryos were injected into one blastomere at the two cell stage with mRNA encoding either dnGCNF (lanes 1-3) , GFP (lanes 4-6) or flGCNF (lanes 7-9). Anterior, middle and posterior thirds were cut from tailbud embryos at stage 30, RNA was extracted and subjected to RT-PCR analysis as detailed in Section 4. (A) cDNA representing fibronectin, xRARg 2 , and EF1a was amplified simultaneously and quantified by means of a phosphorimager and the EF1a band was used as an internal standard. (B) RT-PCR for simultaneous quantification of HoxB9 and EF1a cDNA. entiation of the tail, consistent with the absence of xGCNF from the tailbud in normal embryos at early stages (Fig. 1B and Joos et al., 1996) . The prevalence of head defects after expression of dnGCNF suggests that the toxicity of dnGCNF is due to interference with the endogenous xGCNF, because dnGCNF may be predicted to induce a loss-of-function phenotype since efficient binding of GCNF to its target requires homodimer formation (Chen et al., 1994; Hirose et al., 1995; Joos et al., 1996; Borgmeyer, 1997) . On the other hand, massive overexpression of any nuclear receptor is likely to cause pleiotropic, but less specific effects by trapping of cofactors required for a number of different nuclear hormone receptors and potentially even for other transcription factors (see Ogryzko et al., 1996 , and references therein). Furthermore, massive expression of a full-length or N-terminally truncated receptor might likewise trap a putative ligand and deplete the cell of corepressors or coactivators that bind to the intact Edomain. Since the phenotypes observed after expression of dnGCNF and flGCNF were distinct after injection of moderate doses of mRNA, we suppose that they are characteristic of loss or gain of xGCNF function. Most importantly, the observation that co-expression of flGCNF ameliorated the development of dnGCNF expressing embryos demonstrates that dnGCNF specifically interferes with the normal function of the endogenous GCNF (Fig. 8 and Table 2 ). As expected, complete rescue was not obtained, most probably because of the stochastic nature of dimer formation.
A potential role of xGCNF in somitogenesis
Defects in the somite pattern were observed after overexpression of flGCNF and after expression of dnGCNF (Figs 5, and 11; Table 1 ), indicating that the normal somitogenesis depends on a correct timing and dosage of functional xGCNF in the paraxial mesoderm. Fig. 1B shows an anteroposterior gradient in the amount of xGCNF antigen in the somites, with the lowest level of xGCNF in the posterior somitogenic mesoderm. Overexpression of flGCNF is likely to result in the premature occurrence of xGCNF in cell nuclei of the presomitic mesoderm and thereby interfere with pattern formation. On the other hand, the dnGCNF may interfere with the function of the xGCNF present in the nuclei of somites that have already formed.
A wave of elongation of a zone in the presomitic mesoderm precedes somitogenesis and the somites further elongate after their formation (Elsdale and Davidson, 1983) . Overexpression of GCNF may affect either or both of these elongation processes, and thereby induce abnormally short somites in the area of maximal overexpression (Fig.  5D ). This phenotype is reminiscent of the locally disturbed somite pattern induced by a heat shock prior to somitogenesis (Cooke, 1978) . The ample evidence, both at the structural and molecular level, for the existence of a prepattern in the somitogenic mesoderm of different vertebrate species has recently been reviewed (Gossler and Hrabe de Angelis, 1997; Yamaguchi, 1997) . Interestingly, segmentation but not myogenesis in X. laevis was also disturbed by functional interference with the Notch signaling pathway. This was achieved by expression of antimorphic forms of either the suppressor of Hairless (X-Su(H)), or of the X-Delta-2. Similar to our observations, not only loss of function of the Xenopus X-Delta-2, but also gain of function by overexpression of the same protein resulted in segmentation defects (Jen et al., 1997) .
Potential targets of xGCNF function
As a first approach to screen for potential targets of xGCNF, we have analyzed several marker genes, whose expression is spatiotemporally regulated during embryogenesis of X. laevis, by means of RT-PCR. Due to the anteroposterior gradient of expression of the xGCNF mRNA itself, we dissected the embryos before mRNA extraction in order to examine anterior and posterior anlagen separately. Indeed, dnGCNF interferes with the expression of xRARg 2 mRNA selectively in the anterior third of the tailbud embryo. On the basis of the normal expression pattern of xRARg 2 and xGCNF in early tadpole embryos we suppose that xGCNF interferes with the expression of xRARg 2 in those cells that normally express both receptors, particularly cells in the head mesenchyme (Fig. 1B) and not in cells of the tailtip that do not express xGCNF in significant amounts. Anteriorly, xRARg 2 is supposed to play a role in the differentiation of the head neural crest cells and the head endomesoderm Dreyer, 1991, 1993) . It is likely that xRARg 2 mediates the effects of exogenous retinoids on the differentiation of the brain and sense organs (Durston et al., 1989; Dreyer and Ellinger-Ziegelbauer, 1996) .
Retinoic acid-induced cell differentiation causes a transient increase in GCNF transcription in PCC7-Mz1 (Bauer et al., 1997) and in P19 murine embryonic carcinoma cells (Heinzer et al., 1998) . However, in embryos of X. laevis, we observed no significant change in the expression of xGCNF mRNA or protein after application of a dose of retinoic acid sufficient to induce anterior defects (data not shown).
Putative GCNF response elements are found in the promoter regions of the murine genes for protamine 2 (Yan et al., 1997) , butyrophilin (gb U67065), activin receptor II (gb M93400), the rat hepatocyte nuclear factor 1 gene (gb X67649), and the human genes for the platelet-derived growth factor, PDGF, and for oxytocin (Süsens et al., 1997; Heinzer et al., 1998) . We cannot yet determine whether xRARg 2 is a direct target of xGCNF, because the structure of its promoter is not known. A promoter sequence of one X. laevis fibronectin gene is known (gb Y13284) and does not contain a DR0 motif. Therefore, the expression of fibronectin could be indirectly regulated by GCNF. The apparent excess of extracellular matrix material and the increase in fibronectin mRNA observed after a gain of xGCNF function indicates the regulation of cell to matrix interactions as a potential function of GCNF in organogenesis. The identification of direct GCNF target genes will probably help to clarify the detailed mechanism leading to the phenotypes observed.
xGCNF has a non-redundant function in organogenesis
Our results on organogenic defects caused by loss of GCNF function are in agreement with some observations in GCNF knock-out mice. Complete loss of mGCNF function leads to lethality between day 10.5 and 11.5 of embryonic development. Knock-out mice display defects in organogenesis, including failures in closure of the neural tube (Austin Cooney, personal communication).
In X. laevis, severe spina bifida type failures that displayed after injection of dn or flGCNF mRNA to a variable degree, dependent on the dose of RNA injected and on the batch of eggs, were not evaluated in detail (Table 1) . However, failures in closure of the neural tube were frequently observed on transverse sections of dnGCNF expressing specimens without overt spina bifida (Fig. 7 and data not shown). We therefore suppose that failures in neural tube differentiation including necrotic areas containing cells expressing dnGCNF resulted from a specific loss of function of the endogenous xGCNF (Fig. 7A,D) . Undifferentiated or necrotic cells with high levels of exogenous GCNF protein that had failed to integrate in tissue were also frequently found in edema (data not shown).
Injection of mRNA encoding dnGCNF allowed us to generate a spectrum of phenotypes, that are able to survive because the loss of function was only partial and was transient. Preliminary observations on transgenic frogs indicate that permanent expression of dnGCNF leads to lethality in embryos (M.S. Schwab and C. Dreyer, unpublished data) . Embryonic lethality in the mouse and the distinct phenotypes of X. laevis embryos after interference with xGCNF function suggest that GCNF is a nonredundant prerequisite for the normal sequence of anteroposterior pattern formation during organogenesis.
Experimental procedures
Plasmids and mRNA injection
PCR-fragments coding for amino-acids 1-435 (full length GCNF) and 55-435 (dominant negative GCNF) were generated from the clone pBSKxGCNF (Joos et al., 1996) using the forward primers 5′ttgaattcGATGGACACATGGG-AAG3′ and 5′ttgaattcGAACTGCGTTATGTCGC3′, respectively. The reverse gene-specific primer was 5′ctgctctagaTGATCCAAGTAGCCTC3′. The resulting products were inserted into the EcoRI and XbaI sites of the expression vector pCS2 + MT (Rupp et al., 1994) . These templates for mRNA synthesis are termed pCS2 + MTxGCNF and pCS2 + MTxGCNFDN and encode proteins containing six N-terminal myc-epitopes plus the fulllength or N-terminally truncated xGCNF.
A cDNA fragment coding for the enhanced green fluorescent protein was amplified via PCR using the plasmid pEGFP-C1 (Clontech) as a template and the following primers: forward, 5′cggaattcCATGGTGAGCAAGGGC-GAG3′, reverse, 5′tgaggatatc TTACTTGTACAGCTC-GTCCATGCC3′. The EcoRI/EcoRV digested PCR fragment was cloned into the EcoRI/SnaBI site of the pCS2+ expression vector resulting in pCS2 + MTGFP.
The plasmids were linearized with NotI and 5′-capped mRNA was synthesized with SP6 RNA polymerase using a Message-Machine kit (Ambion). RNA (120 pg) diluted in H 2 O to a volume of 4 nl was microinjected into one or both blastomeres at the 2-cell-stage, whereas blastomeres of embryos at the 32-cell-stage were injected with 30 pg of RNA diluted in 1 nl. The incidence of partial exogastrulation and spina bifida varied from one batch of eggs to another and was significantly less frequent after injection of water instead of mRNA (data not shown). As a control we therefore injected a portion of each batch of embryos with the same amount of mRNA encoding either myc-tagged enhanced green fluorescent protein (GFP) or b-galactosidase (b-gal). Embryos were kept in 1× MBSH until 2 to 5h after injection and then in 0.1× MBSH until fixation. Staging of control embryos was performed according to Nieuwkoop and Faber (1967) . In some experiments, spina bifida phenotypes were considerably more severe after injection of mRNA encoding dn or flGCNF than after control mRNA (data not shown).
Electrophoretic mobility shift assays (EMSA)
EMSA were performed as described in Joos et al. (1996) . Templates for coupled mRNA and protein synthesis in vitro were pSG5-xGCNF (1-1465) for full length xGCNF and pSG5-xGCNF (52-1465) for its N-terminally truncated form.
Western blotting
A polyclonal mouse serum raised against a his-tagged fusion protein containing aa 69 to 435 of xGCNF (essentially domains D, E and F) was affinity-purified as described previously (Joos et al., 1996) and antibodies directed against the six his-tags were removed by application of polyhistidine sepharose (Sigma). Protein extractions from embryos and Western blotting was carried out as described by Schwab and Dreyer (1997) .
Immunostaining
For wholemount immunostaining, embryos were fixed in 4% paraformaldehyde in MEMFA buffer for 3 h at RT and stored in methanol at −20°C until further processing. Before rehydration, embryos were transferred to Dent's fixative (20% DMSO in methanol) and kept at −20°C overnight. Wild type embryos designated for indirect immunoperoxidase staining were, in addition, bleached in 67% methanol, 10% H 2 O 2 , pH 8 under neon light. Embryos were gradually rehydrated in PBS, blocked for 1 h at RT in 20% bovine serum in PBS and subsequently incubated with the primary antibody in 20% bovine serum in PBS for 5 to 24h at RT (anti myc-tag mAB 9E10 and rabbit anti-fibronectin). Peroxidasecoupled secondary antibodies were visualized by incubating the embryos in 0.3 mg/ml DAB, 0.06% H 2 O 2 in PBS. After examination of the embryos under the dissection microscope, 50 mm vibratome sections were prepared and examined with Nomarski optics as described (Hollemann et al., 1996) . Alternatively, embryos were embedded in Technovit (Kultzer) after peroxidase staining and alternating 5 mm thin sections were stained with 0.05% toluidine blue for 1 min or left unstained to facilitate detection of the peroxidase label. For double staining with mouse anti xGCNF and rabbit anti RARg (Ellinger-Ziegelbauer and Dreyer, 1993) , affinity-purified antisera were diluted in 20% bovine serum in PBS containing 0.05% Tween20 and 2.5% DMSO. Incubation was extended to at least 40 h at RT, to ensure complete penetration. After extensive washing overnight, embryos were incubated with the secondary antibody (Cy3-goat anti mouse IgG and DTAF-goat anti rabbit IgG for indirect immunofluorescence and peroxidase coupled goat anti mouse IgG for peroxidase staining) for 5 or 24 h at RT and again washed overnight. For detection of the immunofluorescent label, embryos were embedded in Technovit (Kulzer, Germany), sectioned and counterstained with DAPI as described by Schwab and Dreyer (1997) . Secondary antibodies were from Jackson Immuno Research, West Grove, USA.
In situ hybridization
Albino embryos were injected with two times 120 pg dn or flGCNF mRNA plus 30 or 120 pg of GFP mRNA into each blastomere at the two-cell-stage. At early gastrula stage 10, embryos were selected for significant GFP expression under UV light and fixed between stage 10.25 and 11. Whole mount in situ hybridization was performed essentially as described (Joos et al., 1996) , using digoxigenin-labeled antisense RNA specific of chordin, xbra, and myoDb. After photography, specimens were immunostained with mAB 9E10 for 24 h followed by peroxidase-coupled goat anti mouse IgG to detect myc-tagged proteins.
Microscopy and photography
Fluorescence-labeled Technovit-sections were analyzed under epifluorescence illumination with a Zeiss Axioplan microscope (Zeiss, Oberkochen, FRG) and photographed with Fuji Provia 400 slide film, or with a Sony 3CCD video camera using Analysis software (Soft Imaging Systems, Münster, Germany). Whole mount peroxidase stained embryos were cleared in 33.3% benzyl alcohol in benzoic acid and photographed at a Zeiss Axiovert microscope with Nomarski optics or at a Zeiss Stemi SV 11. All color transparencies were digitized. Images were processed using Adobe Photoshop and Aldus Freehand.
RNA preparation and RT-PCR analysis
Total RNA was isolated from whole embryos at stage 23, from anterior and posterior halves of embryos at stages 23 and 27, and from anterior, middle and posterior thirds of tadpoles at stage 30, using TRIZOL reagent (Gibco, BRL). Analyzing thirds of embryos rather than whole embryos should allow us to monitor more subtle changes that might escape detection, if mRNA from whole embryos were subjected to RT-PCR. Material from five or six individuals was pooled for each RNA preparation. Quantitative RT-PCR was performed as described in Niehrs et al. (1994) . The following primers were used: xRARg 2 : 5′CAGAGCC-CACACTGCTGC3′ and 5′GTCTGGTAGCACCACTTC-C3′; fibronectin: 5′TGACAATGCTCGTAGCTC3′ and 5′-GGTCAATAGGATGGCAAGAG3′; HoxB9: 5′TACTTA-CGGGCTTGGCTGG3′; and 5′GCGTGTAACCAGTTG-GCTG3′; EF1a: 5′CAGATTGGTGCTGGATATGC3′ and 5′ACTGCCTTGATGACTCCTAG3′. The annealing temperature was 57°C for all primer pairs, and the number of cycles resulting in an increase of the amount of the radioactive PCR-product by a factor of two per cycle was optimized for each primer pair (data not shown). For the multipex PCR reactions shown in Fig. 10 , 24 cycles were performed. The product lengths were 552 bp for xRARg 2 , 782 bp for fibronectin, 216 bp for HoxB9, and 279 bp for EF1a. The EF1a-specific cDNA was simultaneously amplified in the same tube as the cDNA under investigation. The radioactive PCR products were separated on 7.5% polyacrylamide gels and were quantified using a phosphorimager (Molecular Dynamics). The intensity of the PCR-product under investigation was routinely normalized to the internal EF1a-standard.
